BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 37526660)

  • 1. Deciphering the immune reaction leading to spontaneous melanoma regression: initial role of MHCII
    Blanc F; Bertho N; Piton G; Leplat JJ; Egidy G; Bourneuf E; Vincent-Naulleau S; Prévost-Blondel A
    Cancer Immunol Immunother; 2023 Nov; 72(11):3507-3521. PubMed ID: 37526660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and histopathological characterization of cutaneous melanomas in the melanoblastoma-bearing Libechov minipig model.
    Vincent-Naulleau S; Le Chalony C; Leplat JJ; Bouet S; Bailly C; Spatz A; Vielh P; Avril MF; Tricaud Y; Gruand J; Horak V; Frelat G; Geffrotin C
    Pigment Cell Res; 2004 Feb; 17(1):24-35. PubMed ID: 14717842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous Regression of Swine Melanoma: The Role of Tumour-infiltrating T and NK Cells.
    Planska D; Horak V
    Anticancer Res; 2023 Feb; 43(2):631-638. PubMed ID: 36697105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanoma-Bearing Libechov Minipig (MeLiM): The Unique Swine Model of Hereditary Metastatic Melanoma.
    Horak V; Palanova A; Cizkova J; Miltrova V; Vodicka P; Kupcova Skalnikova H
    Genes (Basel); 2019 Nov; 10(11):. PubMed ID: 31717496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcription analysis in the MeLiM swine model identifies RACK1 as a potential marker of malignancy for human melanocytic proliferation.
    Egidy G; Julé S; Bossé P; Bernex F; Geffrotin C; Vincent-Naulleau S; Horak V; Sastre-Garau X; Panthier JJ
    Mol Cancer; 2008 Apr; 7():34. PubMed ID: 18442364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between haematological profile and progression or spontaneous regression of melanoma in the Melanoma-bearing Libechov Minipigs.
    Čížková J; Erbanová M; Sochor J; Jindrová A; Strnadová K; Horák V
    Vet J; 2019 Jul; 249():1-9. PubMed ID: 31239158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant features of minipig melanomas prior to spontaneous regression.
    Débare H; Blanc F; Piton G; Leplat JJ; Vincent-Naulleau S; Rivière J; Vilotte M; Marthey S; Lecardonnel J; Coville JL; Estellé J; Rau A; Bourneuf E; Egidy G
    Sci Rep; 2024 Apr; 14(1):9240. PubMed ID: 38649394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of differentially expressed genes in spontaneously regressing melanoma using the MeLiM swine model.
    Rambow F; Malek O; Geffrotin C; Leplat JJ; Bouet S; Piton G; Hugot K; Bevilacqua C; Horak V; Vincent-Naulleau S
    Pigment Cell Melanoma Res; 2008 Apr; 21(2):147-61. PubMed ID: 18426408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new animal model for the imaging of melanoma: correlation of FDG PET with clinical outcome, macroscopic aspect and histological classification in Melanoblastoma-bearing Libechov Minipigs.
    Boisgard R; Vincent-Naulleau S; Leplat JJ; Bouet S; Le Chalony C; Tricaud Y; Horak V; Geffrotin C; Frelat G; Tavitian B
    Eur J Nucl Med Mol Imaging; 2003 Jun; 30(6):826-34. PubMed ID: 12682788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Composition of Circulating Leukocytes Varies With Age and Melanoma Onset in the MeLiM Pig Biomedical Model.
    Blanc F; Prévost-Blondel A; Piton G; Bouguyon E; Leplat JJ; Andréoletti F; Egidy G; Bourneuf E; Bertho N; Vincent-Naulleau S
    Front Immunol; 2020; 11():291. PubMed ID: 32180771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolomic characterisation of progression and spontaneous regression of melanoma in the melanoma-bearing Libechov minipig model.
    Kertys M; Grendar M; Horak V; Zidekova N; Kupcova Skalnikova H; Mokry J; Halasova E; Strnadel J
    Melanoma Res; 2021 Apr; 31(2):140-151. PubMed ID: 33625100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth and regression of cutaneous melanomas in Sinclair miniature swine.
    Oxenhandler RW; Berkelhammer J; Smith GD; Hook RR
    Am J Pathol; 1982 Dec; 109(3):259-69. PubMed ID: 6758603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical characterization of a new melanoma model--the minipig MeLiM strain.
    Borovanský J; Horák V; Elleder M; Fortýn K; Smit NP; Kolb AM
    Melanoma Res; 2003 Dec; 13(6):543-8. PubMed ID: 14646615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue Rebuilding During Spontaneous Regression of Melanoma in the Melanoma-bearing Libechov Minipig.
    Planska D; Kovalska J; Cizkova J; Horak V
    Anticancer Res; 2018 Aug; 38(8):4629-4636. PubMed ID: 30061229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of a CD4 gene haplotype on the immune response in minipigs.
    Blanc F; Créchet F; Bruneau N; Piton G; Leplat JJ; Andréoletti F; Egidy G; Vincent-Naulleau S; Bourneuf E
    Immunogenetics; 2018 Apr; 70(4):209-222. PubMed ID: 29052750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the Microenvironment in Positive and Negative Sentinel Lymph Nodes from Melanoma Patients.
    Messaoudene M; Périer A; Fregni G; Neves E; Zitvogel L; Cremer I; Chanal J; Sastre-Garau X; Deschamps L; Marinho E; Larousserie F; Maubec E; Avril MF; Caignard A
    PLoS One; 2015; 10(7):e0133363. PubMed ID: 26218530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of Immunosuppressive Cells as a Target for Immunotherapies in Melanoma and Non-Melanoma Skin Cancers.
    Fujimura T; Aiba S
    Biomolecules; 2020 Jul; 10(8):. PubMed ID: 32707850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant melanoma in the Sinclair miniature swine: an autopsy study of 60 cases.
    Oxenhandler RW; Adelstein EH; Haigh JP; Hook RR; Clark WH
    Am J Pathol; 1979 Sep; 96(3):707-20. PubMed ID: 474716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KIT and melanoma predisposition in pigs: sequence variants and association analysis.
    Fernández-Rodríguez A; Estellé J; Blin A; Muñoz M; Créchet F; Demenais F; Vincent-Naulleau S; Bourneuf E
    Anim Genet; 2014 Jun; 45(3):445-8. PubMed ID: 24628300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the vascular endothelial growth factor receptor-1 by the monoclonal antibody D16F7 to increase the activity of immune checkpoint inhibitors against cutaneous melanoma.
    Lacal PM; Atzori MG; Ruffini F; Scimeca M; Bonanno E; Cicconi R; Mattei M; Bernardini R; D'Atri S; Tentori L; Graziani G
    Pharmacol Res; 2020 Sep; 159():104957. PubMed ID: 32485280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.